MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Contezolid acefosamil sodium

CAS No. : 1807365-35-0

MCE 站：Contezolid acefosamil sodium

产品活性：Contezolid acefosamil sodium (MRX-4) 是一种新型的恶唑烷酮，用于耐药革兰氏阳性菌引起的皮肤组织感染并发症 (cSSTI) 的抗生素。Contezolid acefosamil sodium (MRX-4) 可显著降低骨髓移植和单胺氧化酶抑制。

研究领域：Anti-infection  |  Neuronal Signaling

作用靶点：Bacterial  |  Antibiotic  |  Monoamine Oxidase

In Vitro: Contezolid (MRX-I) is highly potent against all Grampositive clinical isolates of staphylococci, streptococci, and enterococci, including MDR organisms such as MRSA, methicilline-resistant Streptococcus epidermidis (MRSE), penicillin-resistant Streptococci (PRSP), and VRE.

In Vivo: Oral absorption of Contezolid (MRX-I) occurrs rapidly in mouse, rat, and dog, with peak plasma concentrations observed at 0.5?2.6 h postdose. In mouse, rat, and dog, respectively, PK parameters are determined as follows: dose-normalized C_max/dose was 524, 1065, and 259 ng/mL/(mg/kg); dose-normalized AUC_0?t/dose was 1654, 3703, and 1664 ng?h/mL/(mg/kg); T_1/2 is 1, 1.5, and 3 h; and the oral bioavailability is 69%, 109%, and 37%.
Contezolid (MRX-I) exhibits no obvious toxicity.
Contezolid (MRX-I, 100 mg/kg, once daily) significantly reduced the bacterial load in lungs compared to the untreated early and late controls.

相关产品：Rapamycin  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Chloroquine  |  Puromycin dihydrochloride  |  Cycloheximide  |  Dexamethasone  |  Staurosporine  |  G-418 disulfate  |  Doxycycline (hyclate)  |  Cyclosporin A  |  5-Azacytidine  |  Etoposide  |  Nigericin sodium salt  |  CCCP  |  Actinomycin D  |  Brefeldin A  |  Resveratrol  |  Mitomycin C  |  Wortmannin  |  Hygromycin B  |  Bleomycin sulfate  |  Tunicamycin  |  Tacrolimus  |  Ionomycin  |  Vancomycin hydrochloride  |  Tanespimycin  |  Streptozocin

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。